August 14, 2026 – We received an R01 grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB/NIH) to develop a platform technology for inducing antigen-specific immune tolerance. We are grateful for NIBIB’s support of our research.

March 3, 2026 – Yucheng passed dissertation defense. Congratulations!

September 9, 2024 – We received an R01 grant from NIGMS to develop a PEG alternative for protein delivery. We thank the support from NIH.

June 25, 2024 – Weisi passed her PhD candidacy exam. Congratulations!

June 7, 2024 – Olivia and Amelia won the 1st place in COE Senior Design General Competition. Congratulations!

December 19, 2022 – Our review article titled “Cell delivery devices for cancer immunotherapy” has been accepted for publication in Journal of Controlled Release.

January 8, 2021 – Our research article titled “PEGylation Enables Subcutaneously Administered Nanoparticles to Induce Antigen-Specific Immune Tolerance” has been accepted for publication in Journal of Controlled Release. Congratulations Peter!

July 7, 2020 – Our review article titled “Engineering Long-Circulating Nanomaterial Delivery Systems” has been accepted for publication in Current Opinion in Biotechnology.

June 1, 2020 – Kevin passed his MS thesis defense and will join Merck to start his career in a few months. Congratulations! We wish Kevin a very successful career.

May 29, 2020 – Yucheng passed PhD candidacy exam. Congratulations!